Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Pankaj, Bhargava"'
Publikováno v:
International Journal of Reproductive BioMedicine, Vol 21, Iss 4, Pp 303-322 (2023)
Abstract Background: The male reproductive system undergoes several adverse age-related changes like decreased hormone synthesis, sperm count, and testicular alteration that can impact on fertility. Objective: The study aims to investigate the effect
Externí odkaz:
https://doaj.org/article/9f8182c3cb1d453380c9aa7f133ec36d
Autor:
Nadine Kutsch, Christian Pallasch, Thomas Decker, Holger Hebart, Kai Uwe Chow, Ullrich Graeven, Jens Kisro, Alexander Kroeber, Eugen Tausch, Kirsten Fischer, Anna-Maria Fink, Clemens-Martin Wendtner, Matthias Ritgen, Stephan Stilgenbauer, Danjie Zhang, Biao Li, Juliane M. Jürgensmeier, Nishanthan Rajakumaraswamy, Pankaj Bhargava, Michael Hallek, Barbara Eichhorst
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e729 (2022)
Externí odkaz:
https://doaj.org/article/dcb0aae89c3a4826bbe95658972ef6d0
Autor:
Nadine Kutsch, Christian Pallasch, Eugen Tausch, Volkmar Böhme, Matthias Ritgen, Rüdiger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Kirsten Fischer, Anna-Maria Fink, Stephan Stilgenbauer, Shuyan Zhai, Biao Li, Juliane M. Jürgensmeier, Nishanthan Rajakumaraswamy, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e692 (2022)
Externí odkaz:
https://doaj.org/article/cc1dd22b903a4e9bb9d8ee19e48800b6
Autor:
Christopher D. Fegan, Juliane M. Jürgensmeier, Pankaj Bhargava, Ziqian Zhou, Xi Huang, Rita Humeniuk, Ping Cheng Yi, Siddhartha S. Mitra, Martin J.S. Dyer, Lionel Karlin, Ebenezer A. Kio, Simon A. Rule, Peter Hillmen, Harriet S. Walter, Charles Herbaux, Alexey V. Danilov
Supplemental Figure 3. Mean (SD) TIRA plasma concentration. Cycle 1 Day 8 data are shown in patients receiving TIRA monotherapy with A) TIRA/IDELA, and B) TIRA/ENTO*
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11dcc13096ac288a3c0fe922698b5f6f
https://doi.org/10.1158/1078-0432.22476726.v1
https://doi.org/10.1158/1078-0432.22476726.v1
Autor:
Dan G. Duda, Rakesh K. Jain, David P. Ryan, Charles S. Fuchs, Michelle Knowles, Eamala Vasudev, Eileen Regan, Susan Sheehan, Alona Muzikansky, Pankaj Bhargava, Nadine Jackson McCleary, Thomas A. Abrams, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky, Dushyant V. Sahani, Jeffrey G. Supko, Marek Ancukiewicz, Andrew X. Zhu
Purpose: We conducted a single-arm phase II study of cediranib, a pan-VEGFR tyrosine kinase inhibitor, in patients with advanced hepatocellular carcinoma (HCC).Experimental Design: Patients with histologically confirmed measurable advanced HCC and ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7160077e35660095c7827d46ac4afdae
https://doi.org/10.1158/1078-0432.c.6522066.v1
https://doi.org/10.1158/1078-0432.c.6522066.v1
Autor:
Dan G. Duda, Rakesh K. Jain, David P. Ryan, Charles S. Fuchs, Michelle Knowles, Eamala Vasudev, Eileen Regan, Susan Sheehan, Alona Muzikansky, Pankaj Bhargava, Nadine Jackson McCleary, Thomas A. Abrams, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky, Dushyant V. Sahani, Jeffrey G. Supko, Marek Ancukiewicz, Andrew X. Zhu
PDF file - 159K, Supplementary Table S1: Kinetics of plasma biomarkers and circulating progenitor cells (CPCs) at days 1 and/or 14 during the first cycle of daily 30mg cediranib monotherapy in advanced HCC patients. Supplementary Table S2: Analysis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231bc451c192c12945b6390a090af423
https://doi.org/10.1158/1078-0432.22450974
https://doi.org/10.1158/1078-0432.22450974
Autor:
Christopher D. Fegan, Juliane M. Jürgensmeier, Pankaj Bhargava, Ziqian Zhou, Xi Huang, Rita Humeniuk, Ping Cheng Yi, Siddhartha S. Mitra, Martin J.S. Dyer, Lionel Karlin, Ebenezer A. Kio, Simon A. Rule, Peter Hillmen, Harriet S. Walter, Charles Herbaux, Alexey V. Danilov
Supplemental Table 1 summarizes study inclusion and exclusion criteria. Supplemental Table 2 shows the doses and dose-escalation strategy used in this study. Supplemental Table 3 defines the dose-limiting toxicities that guided dose escalation. Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2661752db628906be946811e30742a6f
https://doi.org/10.1158/1078-0432.22476717
https://doi.org/10.1158/1078-0432.22476717
Autor:
Christopher D. Fegan, Juliane M. Jürgensmeier, Pankaj Bhargava, Ziqian Zhou, Xi Huang, Rita Humeniuk, Ping Cheng Yi, Siddhartha S. Mitra, Martin J.S. Dyer, Lionel Karlin, Ebenezer A. Kio, Simon A. Rule, Peter Hillmen, Harriet S. Walter, Charles Herbaux, Alexey V. Danilov
Supplemental Figure 4. Free BTK levels at baseline and trough TIRA concentration for CLL patients treated with 80 mg TIRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a30975b8192d0017300139da2604cd
https://doi.org/10.1158/1078-0432.22476720.v1
https://doi.org/10.1158/1078-0432.22476720.v1
Autor:
Jaap Verweij, Leni van Doorn, Maarten Thomeer, Herman Burger, Kunihiko Hayashi, Brooke Esteves, Monette M. Cotreau, Toshiyuki Isoe, Pankaj Bhargava, Maja J.A. de Jonge, Ferry A.L.M. Eskens
PDF file - 100K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a563b6adee4ebfe4fd3dd7e464f3432
https://doi.org/10.1158/1078-0432.22444998.v1
https://doi.org/10.1158/1078-0432.22444998.v1
Autor:
Christopher D. Fegan, Juliane M. Jürgensmeier, Pankaj Bhargava, Ziqian Zhou, Xi Huang, Rita Humeniuk, Ping Cheng Yi, Siddhartha S. Mitra, Martin J.S. Dyer, Lionel Karlin, Ebenezer A. Kio, Simon A. Rule, Peter Hillmen, Harriet S. Walter, Charles Herbaux, Alexey V. Danilov
Supplemental Figure 2. Patient disposition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2f892b658eb79b3f7169372bcb174e
https://doi.org/10.1158/1078-0432.22476729
https://doi.org/10.1158/1078-0432.22476729